Development and Characterization of a Novel Vaccine Against Tularemia

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Karl Klose

Funded by

US Dept of Defense

Research Start Date

06/01/2015

Status

Active

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Infectious Disease

Bioscience Research Panel